The enzyme enhancer of zeste homolog 2 (EZH2) is known for its role in transcriptional repression through histone modification, and its overexpression is the culprit for the progression and immune evasion of “cold” prostate cancer (PCa). The gene discussed is EZH2; the disease is prostate carcinoma.